The Role of an Optical Probe in the Detection of Thyroid Cancer and Normal Thyroid Tissue in a Thyroidectomy Specimen: A Pilot Study
The optical real-time readings will be compared to the histological analysis from the same
area. Subjects undergoing thyroid surgery for thyroid disease including thyroid nodules,
thyroid cancer and thyroid goiter with nodules will be eligible to participate. After the
removal of the thyroid gland, optical readings will be taken from the ex vivo thyroid gland
and these same areas will then be analyzed in the usual standard fashion. The reading will
then be correlated with the histological results. In addition, if lymph nodes are removed as
part of the surgery they will also be tested prior to histological standard processing. All
specimens and data will be de-identified.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Assess optical probe for the differentiation of thyroid cancer from normal thyroid tissue and benign thyroid nodules
The objective is to assess a device called an optical probe for the differentiation of thyroid cancer from normal thyroid tissue, benign thyroid nodules or parathyroid glands, and the detection of thyroid cancer within lymph nodes using a hand-held spectroscope, compare the spectra from benign and malignant thyroid nodules and use this to discriminate benign from malignant nodules based on final histopathology or cytology as the gold standard.
two years
No
Jennifer E Rosen, M.D. FACS
Principal Investigator
Boston Medical Center
United States: Institutional Review Board
H28135
NCT01792492
June 2009
November 2013
Name | Location |
---|---|
Boston Medical Center | Boston, Massachusetts 02118 |